XRTX

XORTX Therapeutics
XRTX

6 hedge funds and large institutions have $124K invested in XORTX Therapeutics in 2025 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$128K
2
+$12.4K
3
+$8.35K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$2.48K
5
UBS Group
UBS Group
Switzerland
+$774

Top Sellers

1
-$69.9K
2
-$11.2K
3
-$1
Name Holding Trade Value Shares
Change 		Change in
Stake
DS
1
DRW Securities
Illinois
$109K
TSS
2
Two Sigma Securities
New York
$7.08K
BBA
3
Baader Bank Aktiengesellschaft
Germany
$4.74K
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$2K
UBS Group
5
UBS Group
Switzerland
$787
CA
6
Clearstead Advisors
Ohio
$156
Citadel Advisors
7
Citadel Advisors
Florida
–
XT
8
XTX Topco
Cayman Islands
–
SS
9
SBI Securities
Japan
–